2025-11-19, 6:02:51 a.m.
November 19, 2025 — Leads & Copy — Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) has entered a definitive share purchase agreement on November 19, 2025, to acquire 100% of Alea Health Holdings Ltd., according to a press release. The agreement involves Rocket Doctor AI, Alea Health Holdings Ltd., and Alea’s ordinary shareholders.
The acquisition aims to position Rocket Doctor AI as a leader in AI-driven healthtech, especially in the mental health sector. Alea’s online therapy platform uses conversational AI and voice technology to optimize patient intake, follow-up, and provide continuous support through a 24/7 AI-powered mental health coach. This technology is expected to reduce administrative work and enhance patient engagement and therapeutic matching using sentiment analysis and natural language processing of voice data.
Integrating Alea’s platform with Rocket Doctor AI’s Global Library of Medicine (GLM) will create a unified healthcare solution, expanding the GLM’s mental health capabilities and promoting conversational AI in healthcare over the next decade.
The acquisition also extends Rocket Doctor AI’s reach into the Middle East, particularly the UAE, a key location in the Gulf Cooperation Council (GCC) region. The GCC plans to invest up to $170 billion by 2030 in AI-driven healthcare. Alea’s presence offers Rocket Doctor AI its first major investment in this market, creating opportunities to develop local relationships and modernize healthcare delivery.
The acquisition enhances Rocket Doctor AI’s focus on integrating mental health services with primary care for holistic patient support, complementing the mental health services offered through Rocket Doctor’s digital health platform and marketplace.
Richard Dallala, Alea’s CEO, and Marco Bertetti, CDO/COO, bring over 30 years of combined international experience in AI, machine learning, SaaS, cloud services, and data science. Their expertise in mental health services, telemedicine, and patient intake software will augment Rocket Doctor AI’s capabilities, scaling AI-driven solutions for global healthcare systems.
Dr. Essam Hamza, CEO of Treatment.com AI, stated that the acquisition will help integrate conversational AI and mental health solutions into the healthcare ecosystem, combining Alea’s platform with the GLM to meet the global demand for personalized, AI-driven care and establish a presence in the Middle East market.
Richard Dalalla, CEO of Alea Health, noted that joining Rocket Doctor AI validates their mission to transform mental healthcare using AI and multimodal analysis. He added that integrating their platform with Rocket Doctor AI’s GLM will provide innovative, evidence-based mental health support integrated into primary care, globalizing access to AI-powered therapy.
According to the Definitive Agreement, Rocket Doctor AI will acquire 100% of Alea’s ordinary shares by paying US $15,000 in cash and issuing 285,712 common shares at CAD $0.70 per share. The company will also assume Alea’s obligations under a Simple Agreement for Future Equity (SAFE Note) by paying US $180,000 in monthly installments of US $22,500.
The Proposed Transaction is subject to conditions including employment agreements with key Alea employees and regulatory approvals. Securities issued will have a statutory hold period of 4 months and one day, with Consideration Shares subject to a 28-month escrow release schedule.
Rocket Doctor AI Inc. delivers AI-powered healthcare solutions, including the Global Library of Medicine (GLM), and operates Rocket Doctor Inc, a digital health platform. The platform has helped empower over 300 MDs to provide care to more than 700,000 patient visits.
Rocket Doctor AI aims to make high-quality healthcare accessible, reducing administrative burdens, ensuring consistent care, and reaching underserved communities in Canada and the United States. The company utilizes AI, large language models, and connected medical devices to redefine modern healthcare.
Contact:
Dr. Essam Hamza, CEO, Rocket Doctor AI
essam.hamza@rocketdoctor.ai
media@rocketdoctor.ai
+1 (778) 819 8321
Source: Rocket Doctor AI Inc.
